By Drug Target Review2023-12-20T16:00:28
A new finding that pathological alpha-synuclein causes cells to increase protein synthesis suggests new targets for treating PD.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-25T15:00:00Z 2026-03-25T16:00:00Z
Sponsored by Yokogawa
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
2023-06-20T12:34:32
Sponsored by NanoTemper Technologies
2023-07-03T10:28:23
Sponsored by Merck
2023-11-20T13:43:43
Sponsored by Merck
2023-09-06T16:55:04
Sponsored by NanoTemper Technologies
Site powered by Webvision Cloud